JP2001515502A5 - - Google Patents

Download PDF

Info

Publication number
JP2001515502A5
JP2001515502A5 JP1998540126A JP54012698A JP2001515502A5 JP 2001515502 A5 JP2001515502 A5 JP 2001515502A5 JP 1998540126 A JP1998540126 A JP 1998540126A JP 54012698 A JP54012698 A JP 54012698A JP 2001515502 A5 JP2001515502 A5 JP 2001515502A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998540126A
Other languages
English (en)
Japanese (ja)
Other versions
JP4920124B2 (ja
JP2001515502A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1998/001483 external-priority patent/WO1998041208A1/en
Publication of JP2001515502A publication Critical patent/JP2001515502A/ja
Publication of JP2001515502A5 publication Critical patent/JP2001515502A5/ja
Application granted granted Critical
Publication of JP4920124B2 publication Critical patent/JP4920124B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP54012698A 1997-03-17 1998-03-13 高眼圧を低下させるための組成物及び方法 Expired - Lifetime JP4920124B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81922197A 1997-03-17 1997-03-17
US08/819,221 1997-03-17
PCT/EP1998/001483 WO1998041208A1 (en) 1997-03-17 1998-03-13 Compositions and methods for reducing ocular hypertension

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009235214A Division JP2010043110A (ja) 1997-03-17 2009-10-09 高眼圧を低下させるための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2001515502A JP2001515502A (ja) 2001-09-18
JP2001515502A5 true JP2001515502A5 (cg-RX-API-DMAC10.html) 2005-10-06
JP4920124B2 JP4920124B2 (ja) 2012-04-18

Family

ID=38729083

Family Applications (2)

Application Number Title Priority Date Filing Date
JP54012698A Expired - Lifetime JP4920124B2 (ja) 1997-03-17 1998-03-13 高眼圧を低下させるための組成物及び方法
JP2009235214A Pending JP2010043110A (ja) 1997-03-17 2009-10-09 高眼圧を低下させるための組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009235214A Pending JP2010043110A (ja) 1997-03-17 2009-10-09 高眼圧を低下させるための組成物及び方法

Country Status (32)

Country Link
EP (1) EP0969846B2 (cg-RX-API-DMAC10.html)
JP (2) JP4920124B2 (cg-RX-API-DMAC10.html)
KR (1) KR100555818B1 (cg-RX-API-DMAC10.html)
CN (1) CN1236775C (cg-RX-API-DMAC10.html)
AR (2) AR002194A1 (cg-RX-API-DMAC10.html)
AT (1) ATE257385T1 (cg-RX-API-DMAC10.html)
AU (1) AU738781B2 (cg-RX-API-DMAC10.html)
BR (2) BRPI9816218B1 (cg-RX-API-DMAC10.html)
CA (1) CA2280089C (cg-RX-API-DMAC10.html)
CL (1) CL2009001870A1 (cg-RX-API-DMAC10.html)
CO (1) CO4940427A1 (cg-RX-API-DMAC10.html)
CY (1) CY2526B1 (cg-RX-API-DMAC10.html)
CZ (1) CZ299833B6 (cg-RX-API-DMAC10.html)
DE (1) DE69820997T3 (cg-RX-API-DMAC10.html)
DK (1) DK0969846T4 (cg-RX-API-DMAC10.html)
EE (1) EE04091B1 (cg-RX-API-DMAC10.html)
ES (1) ES2214706T5 (cg-RX-API-DMAC10.html)
HU (1) HU228896B1 (cg-RX-API-DMAC10.html)
ID (1) ID22389A (cg-RX-API-DMAC10.html)
IL (1) IL131041A0 (cg-RX-API-DMAC10.html)
MY (1) MY122237A (cg-RX-API-DMAC10.html)
NO (1) NO327713B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ337322A (cg-RX-API-DMAC10.html)
PE (1) PE61899A1 (cg-RX-API-DMAC10.html)
PL (1) PL197509B1 (cg-RX-API-DMAC10.html)
PT (1) PT969846E (cg-RX-API-DMAC10.html)
RU (1) RU2197970C2 (cg-RX-API-DMAC10.html)
SI (1) SI0969846T2 (cg-RX-API-DMAC10.html)
TW (1) TW527187B (cg-RX-API-DMAC10.html)
UA (1) UA63938C2 (cg-RX-API-DMAC10.html)
WO (1) WO1998041208A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA982188B (cg-RX-API-DMAC10.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
AR002194A1 (es) * 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.
US6187818B1 (en) 1998-06-17 2001-02-13 Pharmacia & Upjohn Company Prostaglandins formulation and process
JP4880808B2 (ja) * 1999-11-15 2012-02-22 久光製薬株式会社 人工涙液型点眼剤組成物
JP4000505B2 (ja) * 1999-12-01 2007-10-31 第一三共株式会社 緑内障を治療するための併用剤
PT1321144E (pt) * 2000-09-13 2011-03-10 Santen Pharmaceutical Co Ltd Colírio
WO2002045748A1 (en) * 2000-12-05 2002-06-13 Sankyo Company, Limited Ocular tension-lowering compositions for topical administration
US20020198209A1 (en) * 2001-05-03 2002-12-26 Allergan Sales Inc. Compositions having enhanced pharmacokinetic characteristics
US7074827B2 (en) * 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma
RU2266572C1 (ru) * 2004-03-17 2005-12-20 Российский государственный медицинский университет Способ моделирования злокачественной артериальной гипертонии
CN1933833B (zh) * 2004-03-18 2011-09-07 株式会社·R-技术上野 含有噻唑衍生物的含水组合物
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
GB0501192D0 (en) * 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
US7851504B2 (en) * 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
DE202005005094U1 (de) * 2005-03-31 2005-07-28 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Ophthalmische Zusammensetzung
US8030349B2 (en) * 2005-08-02 2011-10-04 Santen Pharmaceutical Co., Ltd. Method for prevention of degradation of thermally unstable medicament
JP5252787B2 (ja) * 2005-08-02 2013-07-31 参天製薬株式会社 熱的に不安定な薬物の分解抑制方法
JP2007099647A (ja) * 2005-09-30 2007-04-19 Kobayashi Pharmaceut Co Ltd 粘膜適用組成物
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
WO2007105691A1 (ja) * 2006-03-13 2007-09-20 R-Tech Ueno, Ltd. 水性組成物
KR20140083056A (ko) * 2006-03-17 2014-07-03 존슨 앤드 존슨 비젼 케어, 인코포레이티드 산화에 불안정한 성분을 포함하는 안정화된 안과용 조성물
US20080107644A1 (en) * 2006-10-31 2008-05-08 Alcon Manufacturing, Ltd. Pai-1 binding modulators for the treatment of ocular disorders
EP2123278B1 (en) * 2007-02-07 2013-01-09 Teika Pharmaceutical Co., Ltd. Eye drop preparation comprising latanoprost
JP2009073788A (ja) * 2007-09-21 2009-04-09 Teika Seiyaku Kk イソプロピルウノプロストン含有眼用組成物
CA2702082A1 (en) * 2007-10-08 2009-04-16 Fovea Pharmaceuticals Sa Aqueous ophthalmic formulations
AU2009225931B9 (en) * 2008-03-17 2014-04-03 Novartis Ag Aqueous pharmaceutical compositions containing borate-polyol complexes
TWI544927B (zh) 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
RU2402316C2 (ru) * 2009-01-11 2010-10-27 Пшеничников Виталий Георгиевич Фармацевтическая антиглаукомная композиция
US8952051B2 (en) * 2009-11-05 2015-02-10 Allergan, Inc. Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
CN103596572A (zh) * 2011-04-12 2014-02-19 株式会社·R-技术上野 水性眼用组合物
US20130029919A1 (en) * 2011-07-26 2013-01-31 Allergan, Inc. Two part formulation system for opthalmic delivery
EP2567689A1 (en) 2011-09-12 2013-03-13 Visiotact Pharma Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
PL2787968T3 (pl) 2011-12-07 2020-08-24 Allergan, Inc. Wydajne dostarczanie lipidów do ludzkiego filmu łzowego z użyciem wrażliwego na sól układu emulsyjnego
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
KR102487299B1 (ko) 2014-11-25 2023-01-10 알러간, 인코포레이티드 안정화된 오메가-3 안과용 조성물
US11752175B2 (en) * 2018-09-21 2023-09-12 Cornell University Compositions and methods for glaucoma
CA3136356A1 (en) 2019-04-12 2020-10-15 Ecolab Usa Inc. Antimicrobial multi-purpose cleaner and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2042936C (en) * 1990-05-22 2002-04-30 Ryuji Ueno Treatment of ocular hypertension with a synergistic combination for ophthalmic use
WO1992013836A1 (en) * 1991-02-07 1992-08-20 Allergan, Inc. 2-decarboxyl-2-hydroxyalkyl-5-trans prostaglandin f derivatives
US5767154A (en) * 1991-02-07 1998-06-16 Allergan 5-trans-prostaglandins of the F series and their use as ocular hypotensives
AU684950B2 (en) * 1994-05-06 1998-01-08 Alcon Laboratories, Inc. Use of vitamin E tocopheryl derivatives in ophthalmic compositions
US5631287A (en) † 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
AR002194A1 (es) * 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.

Similar Documents

Publication Publication Date Title
JP2000509635A5 (cg-RX-API-DMAC10.html)
JP2000509637A5 (cg-RX-API-DMAC10.html)
JP2000510751A5 (cg-RX-API-DMAC10.html)
JP2000509942A5 (cg-RX-API-DMAC10.html)
JP2000509912A5 (cg-RX-API-DMAC10.html)
JP2001511255A5 (cg-RX-API-DMAC10.html)
JP2000509587A5 (cg-RX-API-DMAC10.html)
JP2000507369A5 (cg-RX-API-DMAC10.html)
JP2000507433A5 (cg-RX-API-DMAC10.html)
JP2000508866A5 (cg-RX-API-DMAC10.html)
JP2000510793A5 (cg-RX-API-DMAC10.html)
JP2000508841A5 (cg-RX-API-DMAC10.html)
JP2000508680A5 (cg-RX-API-DMAC10.html)
JP2000509853A5 (cg-RX-API-DMAC10.html)
JP2000509755A5 (cg-RX-API-DMAC10.html)
JP2000510969A5 (cg-RX-API-DMAC10.html)
JP2000510247A5 (cg-RX-API-DMAC10.html)
JP2000508836A5 (cg-RX-API-DMAC10.html)
JP2000508102A5 (cg-RX-API-DMAC10.html)
JP2001513629A5 (cg-RX-API-DMAC10.html)
JP2000509818A5 (cg-RX-API-DMAC10.html)
JP2000509520A5 (cg-RX-API-DMAC10.html)
JP2000507434A5 (cg-RX-API-DMAC10.html)
JP2000508880A5 (cg-RX-API-DMAC10.html)
JP2000509754A5 (cg-RX-API-DMAC10.html)